So ACB expects a fair value of only $5.30 on their own stock wrote: Pursuant to the Proposal, CanniMed shareholders will be entitled to receive a maximum of $24 per CanniMed share or 4.52586207 Aurora shares, based on the 20-day volume weighted average price of Aurora
[/quote]
ACB closed at $6.14 today, meaning their are giving away their shares at a much lesser rate, down 15.8% of their trading value. I wonder why they would downplay their own stock, I certainly expect a lower open tomorrow now.
CMED on the other hand should be up a decent chunk.